•PositiveID Corporation Files Patent for its Implantable Glucose Sensor to Continuously Monitor Glucose Levels Over an Extended Period of Time
•PositiveID Corporation Enters Into $4.2 Million Non-Convertible Preferred Stock Purchase Agreement with Socius Technology Capital Group
•PositiveID Corporation Releases Financial Results for Q1 2010
•Revolutionary Glucose Breath Test Attracting Potential Partners
"Industry sources say a significant partnership may be very close to completion and public announcement. Such news would not only help validate the technology, but would also likely send PSID's tightly floated shares upward."
•About the PSID - Stock
No comments:
Post a Comment